The vision of FutureFoodS is to collectively achieve environmentally-friendly, socially secure, fair and economically viable healthy and safe Food Systems (FS) for Europe. FutureFoodS gather 87 partners from 22 EU Member States, 6 Associated Countries and 1 third country. FutureFoodS includes public and private actors, policy makers, foundations, locally, sub-nationally, nationally, EU-widely. All these FutureFoodS partners are fully aligned on the vision for the Partnership and the methodology for its implementation in line with SDG17 and EU Green Deal components. This vision has been broken down into general (GO), specific (SO) and operational (OO) objectives applying across the 4 R&I areas and 4 transversal activities identified by the FutureFoods consortium in its stable draft Strategic Research and Innovation Agenda (SRIA) which constitutes the strategic backbone of the project. The four GO cover: GO1 - Functioning of FS; GO2 - System approaches; GO3 - Inclusive government; GO4 - Co-creation cases. These GO have then been translated into SO prioritised in line with the timescale and resources of the Partnership: SO1 - Change the way we eat; SO2- Change the way we process and supply food, SO3 - Change the way we connect with FSs and SO4 - Change the way we govern FS. In addition, 6 interconnected OO have been set: OO1- Pooling R&I resources and programming; OO2 - Operational FS Observatory; OO3 - Active FS knowledge Hub of FS Labs; OO4 - Functioning knowledge sharing and scaling mechanisms; OO5- Revisiting the SRIA; OO6 - Promoting, supporting, widening & gathering FS various communities. The objectives implemented in the 8 WPs of FutureFoodS will exert impact directly or indirectly in most of the destinations of Horizon Europe’s Cluster 6 2023-2024 work programme and particularly for the topic destination ‘Fair, healthy and environment-friendly FS from primary production to consumption’ echoing to the main EU and World FS policies & strategies.

Antimicrobial resistance (AMR) is a global health challenge with an estimated 67% increase in global deaths attributable to AMR by 2050. The European Partnership One Health AMR (EUP OHAMR) is aiming to reduce the burden of AMR with an integrated One Health (OH) approach, recognising that human, animal and plant health are interdependent and interlinked with the environment. The partnership will boost AMR research and innovation (R&I) addressing the current knowledge gaps with the aim to improve surveillance of resistant pathogens and provide better diagnostics and more effective treatments of drug-resistant infections. It will support implementation research on prevention measures reducing the use of antimicrobials and spread of AMR and launch an ambitious work programme of joint activities to coordinate R&I investments, facilitate the use and re-use of R&I data, strengthen AMR R&I capacities and facilitate both knowledge translation and uptake of research results and innovations by industry, society, and policy makers. The EUP OHAMR builds on the long-standing collaboration of the partners from the Joint Programme Initiative on AMR (JPIAMR) but with a bigger ambition and a broader scope. The partnership consists of 53 partners from 30 countries from the European Union (EU) and beyond. With active engagement of key stakeholders across the AMR landscape, the partnership will strengthen European and global synergies through alignment of research priorities, policies, and investments. Furthermore, EUP OHAMR will support multisectoral and multidisciplinary collaborations to break the existing silos in AMR research. It will result in increased knowledge and solutions and provide an evidence base for uptake into policy and practice to prevent and tackle AMR. Thus, the EUP OHAMR will deliver towards to the priorities set in the European One Health Action plan against AMR, thereby strengthening the European Research and Innovation Area ecosystem and contribute to making the EU a best-practice region on AMR.

Excellent EU programs push health R&I but are not sufficient. Synergy with strategic initiatives in MS and a new model for impactful collaborations are needed to address the challenges for health. ERA4Health brings the opportunity to increase EU transnational collaborative research funding by creating a funding body for joint programming in priority areas addressing EU Public Health Needs, with total duration of 7 years. ERA4Health focuses on tackling diseases and reducing disease burden and the following challenges: 1) the increasing demand for a better quality of life and a better care of patients, 2) the need to transform public health care systems in more effective, efficient, equitable, accessible, and resilient ones and 3) the need to strengthen disease prevention and health promotion. In this view, ERA4Health objectives are: .SO1- Support relevant medical research including clinical fields and intervention areas (prevention, diagnosis, treatment) .SO2- Improve the utilisation of existing health technologies in clinical practice .SO3- Build capacity, in particular in conducting Investigator Initiated Clinical Studies at EU scale .SO4- Implement and advance the practice of RRI across the breadth of the programme ERA4Heatlth will be implemented in 2 phases: . Phase 1 (2 years) will implement joint calls focused on nutrition and lifestyle-related diseases, cardiovascular diseases and nanomedicine (4 in two years). In parallel, it will establish a supporting framework to overcome the challenges in launching international IICSs joint calls. . Phase 2, if the EC approves it: additional multinational calls for IICSs and joint calls for other priority areas will be launched in accordance with the decision of the Health Programme Committee taken at the end of previous Phase 34 partners (20 from EU, 3 Third Countries associated to HE and 2 non-associated, non EU), will commit 90,510,000€, during the 3 first years, as financial support to third parties.

Being one of the main actions of the EU Biodiversity Strategy 2030, the European Biodiversity Partnership (Biodiversa+) will coordinate research programmes between EU and its Member States and Associated Countries, mobilising environmental authorities as key partners for implementing biodiversity research and innovation, along with ministries of research, funding organisations, and environmental protection agencies (75 organisations from 37 countries). Biodiversa+ has five overarching objectives: (1) improve monitoring of biodiversity and ecosystem services across Europe (status and trends); (2) generate actionable knowledge to tackle the direct and indirect drivers of biodiversity loss; (3) expand and improve the evidence base, and accelerate the development and wide deployment of NbS to meet societal challenges across Europe; (4) make the business case for the conservation and restoration of biodiversity; and (5) ensure efficient science-based support for biodiversity policy making in Europe. Biodiversa+ will meet these objectives by (i) setting up a pan-European network of harmonized monitoring schemes, building on existing national/regional monitoring schemes, creating capacity for setting up new schemes, and feeding into the EC Knowledge Center for Biodiversity; (ii) coordinating research programmes between the EU and its Member States and associated countries, thereby ensuring the long-term pan-European research agenda is co-created and implemented; (iii) contributing science-based methodologies to account for and possibly value ecosystem services and the natural capital, and to assess the dependency and impact of businesses on biodiversity and (iv) better linking of R&I programmes to the policy arena, providing greater input to policy making and improving the assessment of policy efficiency. Doing so, Biodiversa+ will help ensure that, by 2030, nature in Europe is back on a path of recovery, and by 2050 people are living in harmony with Nature.

Water is central to all human activities, to all components of the EU Green Deal and to several UN SDGs. The Water4All Partnership aims at enabling water security for all on the long term through boosting systemic transformations and changes across the entire research – water innovation pipeline, fostering the matchmaking between problem owners and solution providers. It gathers more than 70 partners, R&I funders, environment ministries, local authorities, European, national and regional-scale networks, research performing organisations. It will collaborate with other relevant R&I initiatives. Water4All proposes a portfolio of multi-national, cross-sectoral activities, targeting a variety of actors, intending to generate the following outputs: - Strengthen the water R&I collaboration at European and international levels, across at least 31 countries, notably through Joint Transnational Calls - Coordinate and leverage the activities of the Water R&I community - Support and promote the demonstration and access to market of innovative solutions - Produce, share and better communicate water-related knowledge & data, from local to global scales - Enhance talent development of water R&I professionals - Foster capacity development and life-long training of water policy-makers, stakeholders and civil society - Design & implement approaches for participatory development of innovation Water4All will run its activities across 7 themes of its strategic agenda: water for circular economy; water for ecosystems and biodiversity; sustainable water management; water and health; water infrastructure; international cooperation; water governance. Water4All’s outputs will contribute to: - Deliver sound knowledge, tools and evidence basis on water for policy- & decision-making - Improve consideration of water impacts in all relevant policies - Enhance the field/market use of innovative solutions to water challenges - Increase citizens’ awareness and engagement for an inclusive water